Captohasan 25

Captohasan 25 may be available in the countries listed below.

Ingredient matches for Captohasan 25

Captopril

Captopril is reported as an ingredient of Captohasan 25 in the following countries:

• Vietnam

International Drug Name Search

Bupivacain SAD

Bupivacain SAD may be available in the countries listed below.

Ingredient matches for Bupivacain SAD

Bupivacaine

Bupivacaine hydrochloride (a derivative of Bupivacaine) is reported as an ingredient of Bupivacain SAD in the following countries:

• Denmark

International Drug Name Search

Clorhidrat de Papaverinã

Clorhidrat de Papaverinã may be available in the countries listed below.

Ingredient matches for Clorhidrat de Papaverinã

Papaverine

Papaverine hydrochloride (a derivative of Papaverine) is reported as an ingredient of Clorhidrat de Papaverinã in the following countries:

• Romania

International Drug Name Search

GenRX Gliclazide

GenRX Gliclazide may be available in the countries listed below.

Ingredient matches for GenRX Gliclazide

Gliclazide

Gliclazide is reported as an ingredient of GenRX Gliclazide in the following countries:

• Australia

International Drug Name Search

Alendros

Alendros may be available in the countries listed below.

Ingredient matches for Alendros

Alendronic Acid

Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of Alendros in the following countries:

• Czech Republic


• Italy

International Drug Name Search

Tobramycine-Mayne

Tobramycine-Mayne may be available in the countries listed below.

Ingredient matches for Tobramycine-Mayne

Tobramycin

Tobramycin is reported as an ingredient of Tobramycine-Mayne in the following countries:

• Luxembourg

International Drug Name Search

Bromelaina

Bromelaina may be available in the countries listed below.

Ingredient matches for Bromelaina

Bromelains

Bromelaina (DCIT) is also known as Bromelains (Rec.INN)

International Drug Name Search

Glossary

DCIT	Denominazione Comune Italiana
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Dermatop Ointment

Pronunciation: PRED-ni-KAR-bate
Generic Name: Prednicarbate
Brand Name: Dermatop

Dermatop Ointment is used for:

Treating inflammation and itching caused by certain skin conditions. It may also be used for other conditions as determined by your doctor.

Dermatop Ointment is a corticosteroid. Exactly how it works to reduce skin inflammation (redness, swelling, itching, irritation) is not known.

Do NOT use Dermatop Ointment if:

• you are allergic to any ingredient in Dermatop Ointment or to other corticosteroids (eg, prednisone)

Contact your doctor or health care provider right away if any of these apply to you.

Before using Dermatop Ointment:

Some medical conditions may interact with Dermatop Ointment. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have any kind of skin infection, cuts, scrapes, or lessened blood flow to your skin


• if you have had a recent vaccination; have measles, tuberculosis (TB), chickenpox, or shingles; or have had a positive TB test


• if you are taking an oral corticosteroid (eg, prednisone) or similar medicines

Some MEDICINES MAY INTERACT with Dermatop Ointment. Because little, if any, of Dermatop Ointment is absorbed into the blood, the risk of it interacting with another medicine is low.

Ask your health care provider if Dermatop Ointment may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Dermatop Ointment:

Use Dermatop Ointment as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Apply a thin film of medicine to the affected area. Gently rub the medicine in until it is evenly distributed.


• Wash your hands after applying Dermatop Ointment, unless your hands are part of the treated area.


• Do not bandage or wrap the affected area, unless directed otherwise by your doctor.


• If you miss a dose of Dermatop Ointment, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Dermatop Ointment.

Important safety information:

• Do not get Dermatop Ointment in your eyes. If you get Dermatop Ointment in your eyes, rinse them immediately with cool tap water. Do not use Dermatop Ointment on the face, underarms, groin, or diaper areas.


• Do not exceed the recommended dose or use Dermatop Ointment for longer than prescribed without checking with your doctor.


• Serious side effects may occur if too much of Dermatop Ointment is absorbed through the skin. This may be more likely to occur if you use Dermatop Ointment over a large area of the body. It may also be more likely if you wrap or bandage the area after you apply Dermatop Ointment. The risk is greater in children. Do not use more than the prescribed dose. Contact your doctor right away if you develop unusual weight gain (especially in the face), muscle weakness, increased thirst or urination, confusion, unusual drowsiness, severe or persistent headache, or vision changes. Discuss any questions or concerns with your doctor.


• Do not apply Dermatop Ointment over large areas of the body without first checking with your doctor.


• Do not use Dermatop Ointment for other skin conditions at a later time.


• If your symptoms do not improve within 2 weeks or if they become worse, check with your doctor.


• Contact your doctor if you have a cut or sore that does not heal.


• Tell your doctor or dentist that you take Dermatop Ointment before you receive any medical or dental care, emergency care, or surgery.


• Dermatop Ointment contains a corticosteroid. Before you begin taking any new prescription or nonprescription medicine, read the ingredients to see if it contains hydrocortisone or any other corticosteroid. If it does or if you are uncertain, contact your doctor or pharmacist.


• Dermatop Ointment may damage or reduce the effectiveness of latex-containing products (eg, condoms, diaphragms). Latex products that come into contact with Dermatop Ointment should be discarded. Dermatop Ointment is for external use only; do NOT use it in the vagina.


• Caution is advised when using Dermatop Ointment in CHILDREN; they may be more sensitive to its effects.


• Corticosteroids may affect the growth rate in CHILDREN and adolescents in some instances. Your child's growth may need to be checked regularly while using Dermatop Ointment.


• Dermatop Ointment should be used with extreme caution in CHILDREN younger than 10 years old; safety and effectiveness in these children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant while taking Dermatop Ointment, contact your doctor. You will need to discuss the benefits and risks of using Dermatop Ointment while you are pregnant. It is not known if Dermatop Ointment is found in breast milk after topical use. If you are or will be breast-feeding while you use Dermatop Ointment, check with your doctor. Discuss any possible risks to your baby.

Possible side effects of Dermatop Ointment:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Dryness; mild stinging, burning, or itching of the skin.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); acne-like rash; burning, cracking, irritation, pain, peeling, or swelling not present before you began using Dermatop Ointment; excessive hair growth; inflamed hair follicles; inflammation around the mouth; muscle weakness; numbness or tingling; thinning, softening, or discoloration of the skin; unusual weight gain, especially in the face.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Dermatop side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include muscle weakness; severe or persistent headache; symptoms of high blood sugar (eg, increased thirst or urination, confusion, unusual drowsiness); unusual weight gain, especially in the face; vision changes.

Proper storage of Dermatop Ointment:

Store Dermatop Ointment at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Dermatop Ointment out of the reach of children and away from pets.

General information:

• If you have any questions about Dermatop Ointment, please talk with your doctor, pharmacist, or other health care provider.


• Dermatop Ointment is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Dermatop Ointment. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Dermatop resources

• Dermatop Side Effects (in more detail)
• Dermatop Use in Pregnancy & Breastfeeding
• Dermatop Drug Interactions
• Dermatop Support Group
• 0 Reviews for Dermatop - Add your own review/rating

Compare Dermatop with other medications

• Atopic Dermatitis
• Eczema
• Psoriasis
• Skin Rash

Fenilbutazonã

Fenilbutazonã may be available in the countries listed below.

Ingredient matches for Fenilbutazonã

Phenylbutazone

Phenylbutazone is reported as an ingredient of Fenilbutazonã in the following countries:

• Romania

International Drug Name Search

Magnograf

Magnograf may be available in the countries listed below.

Ingredient matches for Magnograf

Gadopentetic Acid

Gadopentetic Acid dimeglumine (a derivative of Gadopentetic Acid) is reported as an ingredient of Magnograf in the following countries:

• Spain


• Switzerland

International Drug Name Search

Merck-Ofloxacine

Merck-Ofloxacine may be available in the countries listed below.

Ingredient matches for Merck-Ofloxacine

Ofloxacin

Ofloxacin is reported as an ingredient of Merck-Ofloxacine in the following countries:

• Luxembourg

International Drug Name Search